Seroprevalence and risk factors for Human papillomavirus in Taiwan

Journal of Tropical Pediatrics

Volumn 54, Issue 1, 2008, Pages 14-18

  Wang, I J ^a,d   Viscidi, R ^b   Hwang, K C ^a   Lin, T Y ^c   Chen, C J ^c,d,e   Huang, L M ^d   Chen, H H ^d  

^a TAIPEI HOSPITAL   (Taiwan)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CHANG GUNG CHILDREN S HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e GENOMICS RESEARCH CENTER   (Taiwan)

Author keywords

HPV 16; Risk factors; Seroprevalence; Vaccination

Indexed keywords

VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DAY CARE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; INFECTION RISK; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIMARY PREVENTION; QUESTIONNAIRE; RISK FACTOR; SCHOOL CHILD; SEROPREVALENCE; SEXUAL BEHAVIOR; TAIWAN; UTERINE CERVIX CANCER; VERRUCA VULGARIS; VIRUS CAPSID; VIRUS PARTICLE;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; INCIDENCE; LOGISTIC MODELS; PAPILLOMAVIRUS INFECTIONS; QUESTIONNAIRES; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; TAIWAN; UTERINE CERVICAL NEOPLASMS;

EID: 39049093340     PISSN: 01426338     EISSN: 14653664     Source Type: Journal    
DOI: 10.1093/tropej/fmm062     Document Type: Article

References (19)

1. Department of Health, Executive Yuax, R.O.C. Cancer Registry Annual Report in Taiwan Area. Taipei: Department of Health, 2001.
2. Miller BA, Ries LAG, Hankey BF, et al. SEER Cancer Statistics Review: 1973-1990, National Cancer Institute. National Institute of Health, Bethesda. NIH Publication; pp. 93-2789, 1993.
3. Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-27.
4. Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. J Natl Cancer Inst 1995;87:796-802.
5. Miller A, Sankaranarayanan R, Bosch X, et al. Can screening for cervical cancer be improved, especially in developing countries? Int J Cancer 2003;107:337-40.
6. Sukvirach S, Smith JS, Tunsakul S, et al. Population-based human papillomavirus prevalence in Lampang and Songkla, Thailand. J Infect Dis 2003;187:1246-56.
7. Shin HR, Lee DH, Herrero R, et al. Prevalence of human papillomavirus infection in women in Busan, South Korea. Int J Cancer 2003;103,413-21.
8. Koch A, Hansen SV, Nielsen NM, et al. HPV detection in children prior to sexual debut. Int J Cancer 1997;73:621-4.
9. af Geijersstam V, Eklund C, Wang Z, et al. A survey of seroprevalence of human papillomavirus types 16, 18 and 33 among childien. Int J Cancer 1999;80:489-93.
10. Stone KM, Karem KL, Stemberg MR, et al. Seroprevalence of human papillomavirus type 16 infection in the United States. J Infect Dis 2002; 186:1396-402.
11. Viscidi RP, Ahdieh-Grant L, Clayman B, et al. Serum immunoglobulin G response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and risk- matched HIV-negative women. J Infect Dis 2003; 187:194-205.
12. Marais D, Rose RC, Williamson AL. Age distribution of antibodies to human papillomavirus in children, women with cervical intraepithelial neoplasia and blood donors from South Africa. J Med Virol 1997; 51:126-31.
13. Cubie HA, Plumstead M, Zhang W, et al. Presence of antibodies to human papillomavirus virus-like particles in 11-13-year-old schoolgirls. J Med, Virol 1998;56: 210-16.
14. Dunne EF, Karem KL, Sternberg MR, et al. Seroprevalence of human papillomavirus type 16 in children. J Infect Dis 2005;191:1817-9.
15. Wang CS, Chou PS. Risk factors for adolescent primigrayida in Kaoshiung County, Taiwan. Am J Prev Med 1999;17:43-7.
16. Wang RH, Wang HH, Hsu MT. Factors associated with adolescent pregnancy - a sample of Taiwanese female adolescents. Public Health Nurs 2003;20:33-41.
17. Kjaer SK, van den Brule, AJ, Bock JE, et al. Determinants for genital human papillomavirus infection in 1000 randomly chosen young Danish women with normal Pap smear: Are there different risk profile for oncogenic and nononcogenic HPV types? Cancer Epidemiol Biomarkers Prev 1997;6: 799-805.
18. Anns A, Strickler HD, Wikktor SZ, et al. Low incidence of human papillomavirus type. 16 antibody seroconversion in young children. Pediatr Infect Dis J 1999;18:833-5.
19. Carter JJ, Koutsky LA, Huges JP, et al. Comparison of human papillomavirus typos 16, 18, and 6 capsid antibody responses following incident infection. J Infect Dis 2000;181:1911-9.